Focus
View

Moderna, Inc.

MRNA · FY2025

ALIGNED

CEO Package

$15.6M

Pay Ratio

Stéphane Bancel

Pay reset -12.7% while TSR improved +29.1 pts

AMGEN INC

AMGN · FY2024

MISALIGNED

CEO Package

$24.4M

Pay Ratio

Robert A. Bradway

Pay rose +7.4% while TSR fell -19.2 pts

GILEAD SCIENCES, INC.

GILD · FY2025

ALIGNED

CEO Package

$28.4M

Pay Ratio

Daniel P. O’Day

Returns outran pay growth by -1.2 pts

CEO Total Compensation — All Companies

MRNA$15.6MAMGN$24.4MGILD$28.4M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

GILD carries the largest package at $28.4M, about 1.8x MRNA.
AMGN reads misaligned, while MRNA looks aligned.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

MRNA

Stéphane Bancel

$15.6M

base salary11%
stock awards44%
option awards44%
other compensation1%

AMGN

Robert A. Bradway

$24.4M

base salary8%
stock awards52%
option awards22%
non-equity incentive compensation16%
other compensation3%

GILD

Daniel P. O’Day

$28.4M

base salary6%
stock awards54%
option awards16%
non-equity incentive compensation17%
other compensation7%

Quick Comparison

CompanyCEOLatest YearTotal Comp
Moderna, Inc.(MRNA)Stéphane Bancel2025$15.6M
AMGEN INC(AMGN)N/A2025N/A
GILEAD SCIENCES, INC.(GILD)Daniel P. O’Day2025$28.4M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.